Table 3.
Estimate | Std. error | t‐value | P‐value | |
---|---|---|---|---|
ΔBMI | 0.238806 | 0.369723 | 0.643 | 0.5253 |
ΔeGFR (mL/min/1.73 m2) | 0.031203 | 0.029639 | 1.053 | 0.3044 |
ΔγGTP (IU/L) | −0.013788 | 0.019971 | −0.69 | 0.4975 |
ΔAST (IU/L) | 0.052287 | 0.055369 | 0.944 | 0.3557 |
ΔALT (IU/L) | −0.068618 | 0.029507 | −2.325 | 0.0301* |
ΔHbA1c (%) | −0.19907 | 0.283503 | −0.702 | 0.4903 |
ΔHDL‐C (mg/dL) | −0.022251 | 0.017289 | −1.287 | 0.2121 |
ΔHOMA‐IR | 0.515829 | 0.182713 | 2.823 | 0.0102* |
ΔSBP (mmHg) | 0.015423 | 0.014045 | 1.098 | 0.2846 |
ΔTG (mg/dL) | 0.00841 | 0.006638 | 1.267 | 0.2191 |
Fibrates (+/−) | 1.055769 | 0.703878 | 1.5 | 0.1485 |
Statins (+/−) | ‐0.552454 | 0.421693 | ‐1.31 | 0.2043 |
R 2 = 0.7421, P‐value = 0.0006316. *P < 0.05. γGTP, gamma‐glutamyl transpeptidase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; eGFR, estimated glomerular filtration rate; HbA1c, glycated hemoglobin; HDL‐C, high‐density lipoprotein cholesterol; HOMA‐IR, homeostatic model assessment of insulin resistance; SBP, systolic blood pressure; Std., standard; TG, triglyceride.